News
Regeneron said Monday it will “prioritize the privacy, security and ethical use” of the personal DNA data from about 15 million people in a $256 million deal to acquire assets of bankrupt ...
An infant in Philadelphia has been successfully treated with a customized Crispr gene-editing therapy for a rare and deadly disease, doctors reported Thursday—a breakthrough in the futuristic ...
ASX eyes eight-day winning streak as rate-cut buzz builds Appen rockets 22pc on profit guidance Burry dumps stocks, bets against Nvidia and China tech The ASX is having a ripper run. Eight straight ...
NEW YORK — Calley Means, a special White House employee and top advisor to HHS Secretary Robert F. Kennedy Jr., effectively dared Roche to pull its … ...
SINGAPORE - Singapore biotech firm Mirxes launched its initial public offering (IPO) in Hong Kong on May 15, aiming to raise HK$1.09 billion (S$181 million) to support stronger growth in the ...
[SINGAPORE] Singapore biotech start-up Mirxes launched its initial public offering (IPO) in Hong Kong on Thursday (May 15) as it seeks to raise HK$1.09 billion (S$181 million) to further grow the ...
ensure the well-being of the dairy industry, and advance the nation’s Atmanirbhar Bharat vision,” said Krishna Ella, founder, Biovet, and executive chairman, Bharat Biotech, in a statement.
St. Renatus LLC, a Fort Collins-based biopharmaceutical company that won Food and Drug Administration approval nine years ago for the nasal-spray dental anesthetic it developed, has filed for Chapter ...
Cash Position: Approximately $1 billion in cash equivalents and time deposits. Legend Biotech Corp (NASDAQ:LEGN) reported a 135% year-over-year increase in net trade sales for CARVYKTI ...
LONDON, May 14 (Reuters) - Some U.S. biotech companies are considering moving early-stage trials of new medicines outside the United States as worry grows that layoffs and policy changes at the ...
Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Novo Nordisk has agreed a partnership worth up to $2.2bn with US biotech Septerna, as the Danish drugmaker ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results